SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
一辉
Lv7
1
4968 积分
2021-05-31 加入
最近求助
最近应助
互助留言
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
7小时前
已完结
Endometrial Cancer
8小时前
已完结
Clinical and translational attributes of immune-related adverse events
8小时前
已完结
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy
3天前
已关闭
Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens
3天前
已完结
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
3天前
已完结
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy
3天前
已完结
Overcoming Primary Resistance to PD-1 Inhibitor With Anti–PD-L1 Agent in Squamous-Cell NSCLC: Case Report
10天前
已完结
Preclinical imaging evaluation of a bispecific antibody targeting hPD1/CTLA4 using humanized mice
21天前
已完结
Good response of cadonilimab (PD-1/CTLA-4 Bi-specific antibody) to patients with advanced lung adenocarcinoma after immunotherapy resistance: A case report
1个月前
已完结
没有进行任何应助
感谢
8小时前
感谢
8小时前
已下载到文献【积分已退回】
3天前
文献错误
3天前
感谢
3天前
感谢
10天前
非文献终稿
10天前
感谢
21天前
感谢
1个月前
感谢
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论